मेराल्जिया पेरेस्थेटिका का उपचार जब रूढ़िवादी प्रबंधन से लक्षण समाप्त नहीं हुए

DOI: 10.1007/s40122-024-00693-4

• Tagliafico et al. [12] treated 20 patients (7 male, 13 female) with perineural injections of 1 mL of methylprednisolone acetate (40 mg/mL) and 8 mL of mepivacaine, 2%, under direct ultrasound guidance.
• Klauser et al. [22] performed injections in 20 patients (9 male, 11 female) using a 27G needle with a mixture of 1 ml triamcinolone acetonide (10 mg/ml), and 5 ml of 0.5% bupivacaine.
• The injection regime was 1 ml of betamethasone disodium phosphate (5 mg/mL) and 2 mL of prilocaine (2%) using a 22G needle.
• Kloosterziel et al. designed a 20-patient double-blind randomised, placebo-controlled trial which compared the injection of 2 mL methylprednisolone/lidocaine (80 mg methylprednisolone, 20 mg lidocaine) with 2 mL saline 0.9%.
• The remaining 4 patients had a further injection and all 20 patients reported complete resolution of symptoms at 2 months.